Human Papillomavirus Vaccine Among Adult Women
- 1 December 2010
- journal article
- research article
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 39 (6) , 559-563
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24–45 years: a randomised, double-blind trialThe Lancet, 2009
- Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey—Adult 2007Preventive Medicine, 2009
- Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 AS04-Adjuvanted Vaccine in Healthy Boys Aged 10–18 YearsJournal of Adolescent Health, 2009
- Ethnic and Sex Variations in Overweight Self‐perception: Relationship to SedentarinessObesity, 2006
- Physical inactivity and overweight among Los Angeles County adultsAmerican Journal of Preventive Medicine, 2004
- African American Elders’ Perceptions of the Influenza Vaccine in Durham, North CarolinaNorth Carolina Medical Journal, 2004
- Meeting the Data Needs of a Local Health Department: The Los Angeles County Health SurveyAmerican Journal of Public Health, 2001